Table 2.

Various PK parameters after oral administration of Niclosamide and ASD-5 in SD rats.

ParameterUnitNiclosamideASD-5Fold-increase (ASD-5 vs. Niclosamide)
Tmaxh0.83 ± 0.290.417 ± 0.144NA
Cmaxng/ml279 ± 142909 ± 1503.26
AUClasth*ng/ml1005 ± 4632334 ± 3212.32
AUCInfh*ng/ml1024 ± 4552387 ± 2432.33
ParameterUnitNiclosamideASD-5Fold-increase (ASD-5 vs. Niclosamide)
Tmaxh0.83 ± 0.290.417 ± 0.144NA
Cmaxng/ml279 ± 142909 ± 1503.26
AUClasth*ng/ml1005 ± 4632334 ± 3212.32
AUCInfh*ng/ml1024 ± 4552387 ± 2432.33

Tmax, time to reach maximum plasma concentration; Cmax, maximum plasma concentration; AUC, area under the curve.

Table 2.

Various PK parameters after oral administration of Niclosamide and ASD-5 in SD rats.

ParameterUnitNiclosamideASD-5Fold-increase (ASD-5 vs. Niclosamide)
Tmaxh0.83 ± 0.290.417 ± 0.144NA
Cmaxng/ml279 ± 142909 ± 1503.26
AUClasth*ng/ml1005 ± 4632334 ± 3212.32
AUCInfh*ng/ml1024 ± 4552387 ± 2432.33
ParameterUnitNiclosamideASD-5Fold-increase (ASD-5 vs. Niclosamide)
Tmaxh0.83 ± 0.290.417 ± 0.144NA
Cmaxng/ml279 ± 142909 ± 1503.26
AUClasth*ng/ml1005 ± 4632334 ± 3212.32
AUCInfh*ng/ml1024 ± 4552387 ± 2432.33

Tmax, time to reach maximum plasma concentration; Cmax, maximum plasma concentration; AUC, area under the curve.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close